beovu 2
For patients with wet AMD 1 THEIR VISION IS A MASTERPIECE NOW APPROVED In two head-to-head trials vs aflibercept, Beovu ® 1 : Demonstrated robust vision gains* 2 Outperformed aflibercept with superior fluid resolution †1,2 Maintained a majority of...Twitter Linkedin Facebook Pinterest Google plus Copy LinkBeovu
What is Beovu? What is Beovu BASIC SUCCINCT STATEMENT Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut...Twitter Linkedin Facebook Pinterest Google plus Copy LinkPatient Support
Beovu home
Beovu (brolucizumab) is an anti–vascular endothelial growth factor (anti-VEGF) treatment for intraocular use. HAWK & HARRIER Clinical Trial Results Learn more→ Dosing and Administration Learn more→ Safety Profile Learn more→ Beovu 120mg/ml solution...Twitter Linkedin Facebook Pinterest Google plus Copy LinkLogged out view
Safety Profile
Superior fluid resolution that lasts1
Superior fluid resolution that lasts1
Robust vision gains1
×
Ask Speakers
×